ARTICLE | Politics, Policy & Law
WHO names former GSK CEO Witty to co-lead COVID-19 vaccine after Trump cuts U.S. funding
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 15, 2020 6:49 PM UTC
Updated on Apr 17, 2020 at 12:16 PM UTC
Andrew Witty will take a leave of absence from his roles as president of UnitedHealth and CEO of the group’s Optum health services unit to co-lead WHO’s program to accelerate the development of COVID-19 vaccines.
Prior to his tenure at UnitedHealth Group Inc. (NYSE:UNH), Witty served as CEO of vaccine manufacturer GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) from 2008 to 2017. ...